Document is current
Any future updates will be listed below
-
Authors
Xue, Chunran
Yu, Haojun
Pei, Xuzhong
Yao, Xiaoying
Ding, Jie
Wang, Xiying
Chen, Yi
Guan, Yangtai https://orcid.org/0000-0001-7322-6842
-
Funding
Funding for this research was provided by:
National Key R&D Program of China (2020YFA0113100)
The Science and Technology Innovation Action Plan of the Science and Technology Commission of Shanghai Municipality (20JC1412000)
- License Information
-
More Information
Article History
Received: 11 October 2024
Accepted: 24 January 2025
First Online: 7 February 2025
Declarations
:
: For animal experiments, (1) Title of the approved project: Therapeutic effect and mechanism of hUC-MSCs on a mouse model of NMOSD; (2) Name of the institutional approval committee or unit: Ethics committee of Shanghai Model Organisms; (3) Approval number: IACUC 2024-0021-1; (4) Date of approval: August, 2024. For human material, (1) Title of the approved project: Prospective multicenter randomized controlled trial of hUC-MSCs for the treatment of NMOSD; (2) Name of the institutional approval committee or unit: Ethics committee of Renji Hospital, Shanghai Jiaotong University School of Medicine; (3) Approval number: 2016-071k; (4) Date of approval: March, 2020. The patients and human donors provided written informed consent for participation in the study and the use of samples.
: Not applicable.
: Not applicable.
